Sign inJoin waitlistJoin the waitlist

Bhuvana Setty

Physician · Nationwide Children's Hospital

Credentials: · ·

History

Nationwide Children's Hospital
2019–Present

Pediatric Hematology/Oncology
Nationwide Children's Hospital
2006–2009
Pediatrics
University of Illinois College of Medicine at Chicago
2003–2006
Shri B.M. Patil Medical College Hospital & Research Centre, B.L.D.E. University
1999–2003

Research

Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases
Pediatric Blood & Cancer · 2012 · First of 3 authors · 143 citations
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial
Molecular Therapy · 2019 · 52 citations
The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss
PLoS Genetics · 2020 · First of 11 authors · 35 citations

Nicholas Yeager
9 papers
Ryan Roberts
8 papers
Timothy Cripe
8 papers
DR
Damon Reed
6 papers
Ajay Gupta
5 papers · 2 as a fellow
Jennifer Aldrink
5 papers
Kathleen Schieffer
5 papers
Thomas Scharschmidt
5 papers
Douglas Hawkins
4 papers
Joshua Palmer
4 papers
Selene Koo
4 papers
Sujith Baliga
4 papers

Clinical trials

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
Principal investigator · Active not recruiting · Phase 2, Phase 3
Children's Oncology Group
2025–2027
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Principal investigator · Recruiting · Phase 1, Phase 2
Nationwide Children's Hospital
2022–2027
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Site PI · Recruiting · Phase 1, Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2026–2031
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Site PI · Recruiting · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2026–2030